Liver fibrosis together with PNPLA3 p.I148M variant affects quality of life in patients with non-alcoholic fatty liver disease: prospective liver stiffness-based study

被引：0
|
作者：
Heintz, Lena [1 ]
Holz, Robert [1 ]
Weber, Susanne N. [1 ]
Lammert, Frank [1 ]
Krawczyk, Marcin [1 ,2 ]
机构：
[1] Saarland Univ Hosp, Dept Internal Med 2, Homburg, Germany
[2] Med Univ Warsaw, Lab Metab Liver Dis, Dept Gen Transplant & Liver Surg, Warsaw, Poland
来源：
JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-303
引用
收藏
页码：E772 / E772
页数：1
相关论文
共 50 条
  • [31] Role of the PNPLA3 I148M Polymorphism in Nonalcoholic Fatty Liver Disease and Fibrosis in Korea
    Lee, Sang Soo
    Byoun, Young-Sang
    Jeong, Sook-Hyang
    Woo, Byung Hyun
    Jang, Eun Sun
    Kim, Jin-Wook
    Kim, Hyun Young
    DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (12) : 2967 - 2974
  • [32] Role of the PNPLA3 I148M Polymorphism in Nonalcoholic Fatty Liver Disease and Fibrosis in Korea
    Sang Soo Lee
    Young-Sang Byoun
    Sook-Hyang Jeong
    Byung Hyun Woo
    Eun Sun Jang
    Jin-Wook Kim
    Hyun Young Kim
    Digestive Diseases and Sciences, 2014, 59 : 2967 - 2974
  • [33] A functional interaction between hepatic estrogen receptor-a and PNPLA3 p.I148M inherited variant drives fatty liver disease susceptibility in women
    Cherubini, Alessandro
    Ostadreza, Mahnoosh
    Jamialahmadi, Oveis
    Pelusi, Serena
    Rrapaj, Eniada
    Casirati, Elia
    Passignani, Giulia
    Baselli, Guido Alessandro
    Ronzoni, Luisa
    Della Torre, Sara
    Dongiovanni, Paola
    Prati, Daniele
    Romeo, Stefano
    Valenti, Luca
    JOURNAL OF HEPATOLOGY, 2023, 78 : S733 - S733
  • [34] The I148M PNPLA3 variant mitigates Niacin beneficial effects: how the genetic screening in Non-alcoholic Fatty Liver Disease (NAFLD) patients gains value
    Paolini, Erika
    Longo, Miriam
    Meroni, Marica
    Malaspina, Gemma
    De Caro, Emilia
    Cespiati, Annalisa
    Lombardi, Rosa
    Fracanzani, Anna Ludovica
    Dongiovanni, Paola
    JOURNAL OF HEPATOLOGY, 2021, 75 : S601 - S602
  • [35] PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
    Aragones, Gemma
    Auguet, Teresa
    Armengol, Sandra
    Berlanga, Alba
    Guiu-Jurado, Esther
    Aguilar, Carmen
    Martinez, Salome
    Sabench, Fatima
    Antonio Porras, Jose
    Daniel Ruiz, Maikel
    Hernandez, Merce
    Josep Sirvent, Joan
    Del Castillo, Daniel
    Richart, Cristobal
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (05)
  • [36] ACTIVITYOF COAGULATION FACTORS IX ANDXIII AND FIBRINOGEN ARE INCREASED IN "OBESE NON-ALCOHOLIC FATTY LIVER DISEASE" BUT NOT IN "PNPLA3 NON-ALCOHOLIC FATTY LIVER DISEASE"
    Lallukka, S.
    Orho-Melander, M.
    Lundbom, N.
    Olkkonen, V. M.
    Yki-Jarvinen, H.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S499 - S499
  • [37] Reply to: HCC and liver disease risk in homozygous PNPLA3 p.I148M carriers approach monogenic inheritance
    Anstee, Quentin M.
    Liu, Yang-Lin
    Day, Christopher P.
    Reeves, Helen L.
    JOURNAL OF HEPATOLOGY, 2015, 62 (04) : 982 - 983
  • [38] The common PNPLA3 variant p.I148M is associated with liver fat contents as quantified by controlled attenuation parameter (CAP)
    Arslanow, Anita
    Stokes, Caroline S.
    Weber, Susanne N.
    Gruenhage, Frank
    Lammert, Frank
    Krawczyk, Marcin
    LIVER INTERNATIONAL, 2016, 36 (03) : 418 - 426
  • [39] A functional interaction between hepatic estrogen receptor-a and PNPLA3 p.I148M inherited variant drives fatty liver disease susceptibility in women
    Cherubini, A.
    Ostadreza, M.
    Jamialahmadi, O.
    Pelusi, S.
    Rrapaj, E.
    Casirati, E.
    Passignani, G.
    Baselli, G.
    Ronzoni, L.
    Dongiovanni, P.
    Prati, D.
    Romeo, S.
    Valenti, L.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S13 - S13
  • [40] Estrogen-ER-α axis induces PNPLA3 p.I148M protein variant to promote steatotic liver disease susceptibility in women
    Cherubini, Alessandro
    Casirati, Elia
    Pelusi, Serena
    Valenti, Luca
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (01):
12345